Anti-idiotype tumor vaccines.
Anti-idiotype tumor vaccines.
复制标题
抗独特型肿瘤疫苗。
DOI:
10.1007/978-1-4757-2046-4_9
复制
发表时间:
1989
影响因子:
--
通讯作者:
Kohler,H
中科院分区:
文献类型:
--
作者:
Bhattacharya-Chatterjee,M;Kohler,H
The immunotherapy of human cancer using tumor cells or tumor-derived vaccines has been disappointing for several reasons. It has been consistently difficult to obtain large quantities of pure tumor antigens which are often chemically ill-defined and difficult to purify. In addition, there is the question whether there exists truly tumor-specific antigens and finally, there remains the problem of the immunobiological response potential against tumor antigens, or in other words, the question whether a cancer patient can mount effectively an immune response against his tumor. Tumor-associated antigens are often a part of “self” and usually evoke a very poor immune response in a tumor-bearing host due to a state of T cell-mediated suppression (Haubeck and Kolsch, 1982; Howie and McBride, 1982) and also because of tolerance to the antigen (Greene, 1980; McBride and Howie, 1986). Immunobiologists have learned that a poor antigen can be turned into a strong antigen by simply changing the molecular environment of the haptenic structure. Such changes of the carrier for haptens allow T cell help to become active, making the overall immune response stronger.
登录
查看更多内容
影响因子:
3.6
作者:
Seon,BK;Fukukawa,T;Jackson,AL;Chervinsky,D;Tebbi,CK;Freeman,AI;Matsuzaki,H
通讯作者:
Matsuzaki,H
影响因子:
20.3
作者:
S. Sallan;J. Ritz;J. Pesando;R. Gelber;C. O'Brien;S. Hitchcock;F. Coral;S. Schlossman
通讯作者:
S. Schlossman
DOI:
10.1126/science.3952496
发表时间:
1986
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Herlyn,D;Ross,AH;Koprowski,H
通讯作者:
Koprowski,H
DOI:
10.1016/0090-1229(81)90228-2
发表时间:
1981-01-01
期刊:
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY
影响因子:
--
作者:
NISONOFF, A;LAMOYI, E
通讯作者:
LAMOYI, E
影响因子:
4.4
作者:
Michael J. Campbell;William L. Carroll;Shinichiro Kon;Kristiaan Thielemans;Jonathan B. Rothbard;S. Levy-S.
通讯作者:
Michael J. Campbell;William L. Carroll;Shinichiro Kon;Kristiaan Thielemans;Jonathan B. Rothbard;S. Levy-S.